{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T04:00:40Z","timestamp":1792641640502,"version":"4.5.0"},"reference-count":184,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,5]],"date-time":"2026-01-05T00:00:00Z","timestamp":1767571200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,1,5]],"date-time":"2026-01-05T00:00:00Z","timestamp":1767571200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100004442","name":"National Science Centre","doi-asserted-by":"crossref","award":["2021\/03\/Y\/NZ4\/00214"],"award-info":[{"award-number":["2021\/03\/Y\/NZ4\/00214"]}],"id":[{"id":"10.13039\/501100004442","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pharmacol. Rep"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1007\/s43440-025-00819-1","type":"journal-article","created":{"date-parts":[[2026,1,5]],"date-time":"2026-01-05T01:17:37Z","timestamp":1767575857000},"page":"1-26","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Mitochondria as a therapeutic target in neurodegeneration caused by hypoxia and ischemia during the perinatal period"],"prefix":"10.1007","volume":"78","author":[{"given":"Micha\u0142","family":"Fra\u0144czak","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Justyna","family":"Garga\u015b","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joanna","family":"Sypecka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,1,5]]},"reference":[{"key":"819_CR1","doi-asserted-by":"publisher","unstructured":"Min YJ, Ling EA, Li F. Immunomodulatory mechanism and potential therapies for perinatal hypoxic-ischemic brain damage. Front Pharmacol. 2020;11. https:\/\/doi.org\/10.3389\/fphar.2020.580428.","DOI":"10.3389\/fphar.2020.580428"},{"key":"819_CR2","unstructured":"Gillam-Krakauer M, Shah M, Gowen CW Jr. Birth Asphyxia. 2025."},{"key":"819_CR3","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1007\/s13760-020-01308-3","volume":"120","author":"P Greco","year":"2020","unstructured":"Greco P, Nencini G, Piva I, Scioscia M, Volta CA, Spadaro S, et al. Pathophysiology of hypoxic\u2013ischemic encephalopathy: a review of the past and a view on the future. Acta Neurol Belg. 2020;120:277\u201388. https:\/\/doi.org\/10.1007\/s13760-020-01308-3.","journal-title":"Acta Neurol Belg"},{"key":"819_CR4","doi-asserted-by":"publisher","first-page":"833","DOI":"10.3390\/ijms22020833","volume":"22","author":"H Mohsenpour","year":"2021","unstructured":"Mohsenpour H, Pesce M, Patruno A, Bahrami A, Pour PM, Farzaei MH. A review of plant extracts and plant-Derived natural compounds in the Prevention\/Treatment of neonatal Hypoxic-Ischemic brain injury. Int J Mol Sci. 2021;22:833. https:\/\/doi.org\/10.3390\/ijms22020833.","journal-title":"Int J Mol Sci"},{"key":"819_CR5","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1016\/j.ceca.2004.02.016","volume":"36","author":"T Kristi\u00e1n","year":"2004","unstructured":"Kristi\u00e1n T. Metabolic stages, mitochondria and calcium in hypoxic\/ischemic brain damage. Cell Calcium. 2004;36:221\u201333. https:\/\/doi.org\/10.1016\/j.ceca.2004.02.016.","journal-title":"Cell Calcium"},{"key":"819_CR6","doi-asserted-by":"publisher","first-page":"547","DOI":"10.3390\/antiox13050547","volume":"13","author":"E D\u2019Apolito","year":"2024","unstructured":"D\u2019Apolito E, Sisalli MJ, Tufano M, Annunziato L, Scorziello A. Oxidative metabolism in brain ischemia and preconditioning: two sides of the same coin. Antioxidants. 2024;13:547. https:\/\/doi.org\/10.3390\/antiox13050547.","journal-title":"Antioxidants"},{"key":"819_CR7","doi-asserted-by":"publisher","first-page":"1550","DOI":"10.1002\/jnr.24821","volume":"99","author":"MW Chen","year":"2021","unstructured":"Chen MW, Santos P, Kulikowicz E, Koehler RC, Lee JK, Martin LJ. Targeting the mitochondrial permeability transition pore for neuroprotection in a piglet model of neonatal hypoxic-ischemic encephalopathy. J Neurosci Res. 2021;99:1550\u201364. https:\/\/doi.org\/10.1002\/jnr.24821.","journal-title":"J Neurosci Res"},{"key":"819_CR8","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1016\/j.pneurobio.2016.06.006","volume":"157","author":"PB Ham","year":"2017","unstructured":"Ham PB, Raju R. Mitochondrial function in hypoxic ischemic injury and influence of aging. Prog Neurobiol. 2017;157:92\u2013116. https:\/\/doi.org\/10.1016\/j.pneurobio.2016.06.006.","journal-title":"Prog Neurobiol"},{"key":"819_CR9","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/j.neuroscience.2015.05.078","volume":"301","author":"TH Sanderson","year":"2015","unstructured":"Sanderson TH, Raghunayakula S, Kumar R. Neuronal hypoxia disrupts mitochondrial fusion. Neuroscience. 2015;301:71\u20138. https:\/\/doi.org\/10.1016\/j.neuroscience.2015.05.078.","journal-title":"Neuroscience"},{"key":"819_CR10","doi-asserted-by":"publisher","first-page":"8512","DOI":"10.3390\/ijms23158512","volume":"23","author":"AE Sifat","year":"2022","unstructured":"Sifat AE, Nozohouri S, Archie SR, Chowdhury EA, Abbruscato TJ. Brain energy metabolism in ischemic stroke: effects of smoking and diabetes. Int J Mol Sci. 2022;23:8512. https:\/\/doi.org\/10.3390\/ijms23158512.","journal-title":"Int J Mol Sci"},{"key":"819_CR11","doi-asserted-by":"publisher","first-page":"2196","DOI":"10.1016\/j.jacc.2024.02.056","volume":"83","author":"FGP Welt","year":"2024","unstructured":"Welt FGP, Batchelor W, Spears JR, Penna C, Pagliaro P, Ibanez B, et al. Reperfusion injury in patients with acute myocardial infarction: JACC scientific statement. J Am Coll Cardiol. 2024;83:2196\u2013213. https:\/\/doi.org\/10.1016\/j.jacc.2024.02.056.","journal-title":"J Am Coll Cardiol"},{"key":"819_CR12","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1007\/s00395-024-01060-2","volume":"119","author":"E Bertero","year":"2024","unstructured":"Bertero E, Popoiu T-A, Maack C. Mitochondrial calcium in cardiac ischemia\/reperfusion injury and cardioprotection. Basic Res Cardiol. 2024;119:569\u201385. https:\/\/doi.org\/10.1007\/s00395-024-01060-2.","journal-title":"Basic Res Cardiol"},{"key":"819_CR13","doi-asserted-by":"publisher","unstructured":"Nhu NT, Li Q, Liu Y, Xu J, Xiao S-Y, Lee S-D. Effects of Mdivi-1 on neural mitochondrial dysfunction and mitochondria-mediated apoptosis in ischemia-reperfusion injury after stroke: a systematic review of preclinical studies. Front Mol Neurosci. 2021;14. https:\/\/doi.org\/10.3389\/fnmol.2021.778569.","DOI":"10.3389\/fnmol.2021.778569"},{"key":"819_CR14","doi-asserted-by":"publisher","first-page":"2859","DOI":"10.1016\/j.bbadis.2018.05.018","volume":"1864","author":"Y Xi","year":"2018","unstructured":"Xi Y, Feng D, Tao K, Wang R, Shi Y, Qin H, et al. MitoQ protects dopaminergic neurons in a 6-OHDA induced PD model by enhancing Mfn2-dependent mitochondrial fusion via activation of PGC-1\u03b1. Biochimica et biophysica acta (BBA) -. Mol Basis Disease. 2018;1864:2859\u201370. https:\/\/doi.org\/10.1016\/j.bbadis.2018.05.018.","journal-title":"Mol Basis Disease"},{"key":"819_CR15","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1186\/s12974-025-03363-0","volume":"22","author":"G Zhang","year":"2025","unstructured":"Zhang G, Wei H, Zhao A, Yan X, Zhang X, Gan J, et al. Mitochondrial DNA leakage: underlying mechanisms and therapeutic implications in neurological disorders. J Neuroinflammation. 2025;22:34. https:\/\/doi.org\/10.1186\/s12974-025-03363-0.","journal-title":"J Neuroinflammation"},{"key":"819_CR16","doi-asserted-by":"publisher","unstructured":"Halliwell B, Gutteridge JMC. Free radicals in biology and medicine. 5th ed. Oxford: Oxford University Press; 2015. https:\/\/doi.org\/10.1093\/acprof:oso\/9780198717478.001.0001.","DOI":"10.1093\/acprof:oso\/9780198717478.001.0001"},{"key":"819_CR17","doi-asserted-by":"publisher","first-page":"276","DOI":"10.3390\/cells14040276","volume":"14","author":"H-M Yang","year":"2025","unstructured":"Yang H-M. Mitochondrial dysfunction in neurodegenerative diseases. Cells. 2025;14:276. https:\/\/doi.org\/10.3390\/cells14040276.","journal-title":"Cells"},{"key":"819_CR18","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1186\/s12967-023-04493-w","volume":"21","author":"FA Bustamante-Barrientos","year":"2023","unstructured":"Bustamante-Barrientos FA, Luque-Campos N, Araya MJ, Lara-Barba E, de Solminihac J, Pradenas C, et al. Mitochondrial dysfunction in neurodegenerative disorders: potential therapeutic application of mitochondrial transfer to central nervous system-residing cells. J Transl Med. 2023;21:613. https:\/\/doi.org\/10.1186\/s12967-023-04493-w.","journal-title":"J Transl Med"},{"key":"819_CR19","doi-asserted-by":"publisher","unstructured":"Edwards R, Eaglesfield R, Tokatlidis K. The mitochondrial intermembrane space: the most constricted mitochondrial sub-compartment with the largest variety of protein import pathways. Open Biol. 2021;11. https:\/\/doi.org\/10.1098\/rsob.210002.","DOI":"10.1098\/rsob.210002"},{"key":"819_CR20","doi-asserted-by":"publisher","first-page":"762","DOI":"10.1095\/biolreprod.108.074013","volume":"80","author":"T Aihara","year":"2009","unstructured":"Aihara T, Nakamura N, Honda S, Hirose S. A novel potential role for Gametogenetin-Binding protein 1 (GGNBP1) in mitochondrial morphogenesis during spermatogenesis in Mice1. Biol Reprod. 2009;80:762\u201370. https:\/\/doi.org\/10.1095\/biolreprod.108.074013.","journal-title":"Biol Reprod"},{"key":"819_CR21","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1038\/s41556-018-0124-1","volume":"20","author":"JB Spinelli","year":"2018","unstructured":"Spinelli JB, Haigis MC. The multifaceted contributions of mitochondria to cellular metabolism. Nat Cell Biol. 2018;20:745\u201354. https:\/\/doi.org\/10.1038\/s41556-018-0124-1.","journal-title":"Nat Cell Biol"},{"key":"819_CR22","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.tcb.2024.05.001","volume":"35","author":"O Rackham","year":"2025","unstructured":"Rackham O, Saurer M, Ban N, Filipovska A. Unique architectural features of mammalian mitochondrial protein synthesis. Trends Cell Biol. 2025;35:11\u201323. https:\/\/doi.org\/10.1016\/j.tcb.2024.05.001.","journal-title":"Trends Cell Biol"},{"key":"819_CR23","doi-asserted-by":"publisher","first-page":"e3002671","DOI":"10.1371\/journal.pbio.3002671","volume":"22","author":"N Preminger","year":"2024","unstructured":"Preminger N, Schuldiner M. Beyond fission and fusion\u2014Diving into the mysteries of mitochondrial shape. PLoS Biol. 2024;22:e3002671. https:\/\/doi.org\/10.1371\/journal.pbio.3002671.","journal-title":"PLoS Biol"},{"key":"819_CR24","doi-asserted-by":"publisher","first-page":"117084","DOI":"10.1016\/j.biopha.2024.117084","volume":"178","author":"S Chen","year":"2024","unstructured":"Chen S, Li Q, Shi H, Li F, Duan Y, Guo Q. New insights into the role of mitochondrial dynamics in oxidative stress-induced diseases. Biomed Pharmacother. 2024;178:117084. https:\/\/doi.org\/10.1016\/j.biopha.2024.117084.","journal-title":"Biomed Pharmacother"},{"key":"819_CR25","doi-asserted-by":"publisher","first-page":"e00292","DOI":"10.1016\/j.neurot.2023.10.002","volume":"21","author":"MM Klemmensen","year":"2024","unstructured":"Klemmensen MM, Borrowman SH, Pearce C, Pyles B, Chandra B. Mitochondrial dysfunction in neurodegenerative disorders. Neurotherapeutics. 2024;21:e00292. https:\/\/doi.org\/10.1016\/j.neurot.2023.10.002.","journal-title":"Neurotherapeutics"},{"key":"819_CR26","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1038\/s41392-025-02253-4","volume":"10","author":"X Xu","year":"2025","unstructured":"Xu X, Pang Y, Fan X. Mitochondria in oxidative stress, inflammation and aging: from mechanisms to therapeutic advances. Signal Transduct Target Ther. 2025;10:190. https:\/\/doi.org\/10.1038\/s41392-025-02253-4.","journal-title":"Signal Transduct Target Ther"},{"key":"819_CR27","doi-asserted-by":"publisher","first-page":"e21620","DOI":"10.1096\/fj.202100067R","volume":"35","author":"M Adebayo","year":"2021","unstructured":"Adebayo M, Singh S, Singh AP, Dasgupta S. Mitochondrial fusion and fission: the fine-tune balance for cellular homeostasis. FASEB J. 2021;35:e21620. https:\/\/doi.org\/10.1096\/fj.202100067R.","journal-title":"FASEB J"},{"key":"819_CR28","doi-asserted-by":"publisher","first-page":"2601","DOI":"10.1016\/j.cell.2024.04.037","volume":"187","author":"A Suomalainen","year":"2024","unstructured":"Suomalainen A, Nunnari J. Mitochondria at the crossroads of health and disease. Cell. 2024;187:2601\u201327. https:\/\/doi.org\/10.1016\/j.cell.2024.04.037.","journal-title":"Cell"},{"key":"819_CR29","doi-asserted-by":"publisher","unstructured":"Wang S, Tan J, Miao Y, Zhang Q. Mitochondrial dynamics, mitophagy, and mitochondria\u2013endoplasmic reticulum contact sites crosstalk under hypoxia. Front Cell Dev Biol. 2022;10. https:\/\/doi.org\/10.3389\/fcell.2022.848214.","DOI":"10.3389\/fcell.2022.848214"},{"key":"819_CR30","doi-asserted-by":"publisher","unstructured":"Yang D, Ying J, Wang X, Zhao T, Yoon S, Fang Y, et al. Mitochondrial dynamics: a key role in neurodegeneration and a potential target for neurodegenerative disease. Front Neurosci. 2021;15. https:\/\/doi.org\/10.3389\/fnins.2021.654785.","DOI":"10.3389\/fnins.2021.654785"},{"key":"819_CR31","doi-asserted-by":"publisher","unstructured":"Zhou X, Chen H, Wang L, Lenahan C, Lian L, Ou Y, et al. Mitochondrial dynamics: a potential therapeutic target for ischemic stroke. Front Aging Neurosci. 2021;13. https:\/\/doi.org\/10.3389\/fnagi.2021.721428.","DOI":"10.3389\/fnagi.2021.721428"},{"key":"819_CR32","doi-asserted-by":"publisher","first-page":"115247","DOI":"10.1016\/j.biopha.2023.115247","volume":"165","author":"Y Huan","year":"2023","unstructured":"Huan Y, Hao G, Shi Z, Liang Y, Dong Y, Quan H. The role of dynamin-related protein 1 in cerebral ischemia\/hypoxia injury. Biomed Pharmacother. 2023;165:115247. https:\/\/doi.org\/10.1016\/j.biopha.2023.115247.","journal-title":"Biomed Pharmacother"},{"key":"819_CR33","doi-asserted-by":"publisher","first-page":"101706","DOI":"10.1016\/j.redox.2020.101706","volume":"37","author":"C Duan","year":"2020","unstructured":"Duan C, Wang L, Zhang J, Xiang X, Wu Y, Zhang Z, et al. Mdivi-1 attenuates oxidative stress and exerts vascular protection in ischemic\/hypoxic injury by a mechanism independent of Drp1 GTPase activity. Redox Biol. 2020;37:101706. https:\/\/doi.org\/10.1016\/j.redox.2020.101706.","journal-title":"Redox Biol"},{"key":"819_CR34","doi-asserted-by":"publisher","first-page":"19673","DOI":"10.1038\/s41598-024-69748-y","volume":"14","author":"N Marx","year":"2024","unstructured":"Marx N, Ritter N, Disse P, Seebohm G, Busch KB. Detailed analysis of Mdivi-1 effects on complex I and respiratory supercomplex assembly. Sci Rep. 2024;14:19673. https:\/\/doi.org\/10.1038\/s41598-024-69748-y.","journal-title":"Sci Rep"},{"key":"819_CR35","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1007\/s12035-025-05484-2","volume":"63","author":"XM Liu","year":"2026","unstructured":"Liu XM, Chen F, Cheng YJ, Wang DP. Inhibition of DRP1-mediated mitochondrial fission and NRF2\/HO-1\/GPX4-mediated ferroptosis by Mdivi-1 protects against vascular cognitive impairment. Mol Neurobiol. 2026;63:76. https:\/\/doi.org\/10.1007\/s12035-025-05484-2.","journal-title":"Mol Neurobiol"},{"key":"819_CR36","doi-asserted-by":"publisher","unstructured":"Yao C-H, Wang R, Wang Y, Kung C-P, Weber JD, Patti GJ. Mitochondrial fusion supports increased oxidative phosphorylation during cell proliferation. Elife. 2019;8. https:\/\/doi.org\/10.7554\/eLife.41351.","DOI":"10.7554\/eLife.41351"},{"key":"819_CR37","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1242\/jcs.171017","volume":"130","author":"KH Flippo","year":"2017","unstructured":"Flippo KH, Strack S. Mitochondrial dynamics in neuronal injury, development and plasticity. J Cell Sci. 2017;130:671\u201381. https:\/\/doi.org\/10.1242\/jcs.171017.","journal-title":"J Cell Sci"},{"key":"819_CR38","doi-asserted-by":"publisher","first-page":"3421","DOI":"10.1523\/JNEUROSCI.1356-22.2023","volume":"43","author":"JD Vevea","year":"2023","unstructured":"Vevea JD, Chapman ER. Mitofusin 2 sustains the axonal mitochondrial network to support presynaptic Ca 2+ homeostasis and the synaptic vesicle cycle in rat hippocampal axons. J Neurosci. 2023;43:3421\u201338. https:\/\/doi.org\/10.1523\/JNEUROSCI.1356-22.2023.","journal-title":"J Neurosci"},{"key":"819_CR39","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1016\/j.bbadis.2012.07.009","volume":"1832","author":"ME Solesio","year":"2013","unstructured":"Solesio ME, Prime TA, Logan A, Murphy MP, del Mar Arroyo-Jimenez M, Jord\u00e1n J, et al. The mitochondria-targeted anti-oxidant MitoQ reduces aspects of mitochondrial fission in the 6-OHDA cell model of parkinson\u2019s disease. Biochimica et biophysica acta (BBA) -. Mol Basis Disease. 2013;1832:174\u201382. https:\/\/doi.org\/10.1016\/j.bbadis.2012.07.009.","journal-title":"Mol Basis Disease"},{"key":"819_CR40","doi-asserted-by":"publisher","unstructured":"Chen L, Qin Y, Liu B, Gao M, Li A, Li X, et al. PGC-1\u03b1-mediated mitochondrial quality control: molecular mechanisms and implications for heart failure. Front Cell Dev Biol. 2022;10. https:\/\/doi.org\/10.3389\/fcell.2022.871357.","DOI":"10.3389\/fcell.2022.871357"},{"key":"819_CR41","doi-asserted-by":"publisher","first-page":"H682","DOI":"10.1152\/ajpheart.00617.2019","volume":"318","author":"S Kim","year":"2020","unstructured":"Kim S, Song J, Ernst P, Latimer MN, Ha C-M, Goh KY, et al. MitoQ regulates redox-related noncoding RNAs to preserve mitochondrial network integrity in pressure-overload heart failure. Am J Physiol Heart Circ Physiol. 2020;318:H682\u201395. https:\/\/doi.org\/10.1152\/ajpheart.00617.2019.","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"819_CR42","doi-asserted-by":"publisher","first-page":"S109","DOI":"10.3233\/JAD-201074","volume":"82","author":"A Merelli","year":"2021","unstructured":"Merelli A, Repetto M, Lazarowski A, Auzmendi J, Hypoxia. Oxidative Stress, and inflammation: three faces of neurodegenerative diseases. J Alzheimer\u2019s Disease. 2021;82:S109\u201326. https:\/\/doi.org\/10.3233\/JAD-201074.","journal-title":"J Alzheimer\u2019s Disease"},{"key":"819_CR43","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/s12964-023-01398-5","volume":"22","author":"MJ Iqbal","year":"2024","unstructured":"Iqbal MJ, Kabeer A, Abbas Z, Siddiqui HA, Calina D, Sharifi-Rad J, et al. Interplay of oxidative stress, cellular communication and signaling pathways in cancer. Cell Communication Signal. 2024;22:7. https:\/\/doi.org\/10.1186\/s12964-023-01398-5.","journal-title":"Cell Communication Signal"},{"key":"819_CR44","doi-asserted-by":"publisher","first-page":"e127","DOI":"10.1002\/mco2.127","volume":"3","author":"J Zuo","year":"2022","unstructured":"Zuo J, Zhang Z, Luo M, Zhou L, Nice EC, Zhang W, et al. Redox signaling at the crossroads of human health and disease. MedComm (Beijing). 2022;3:e127. https:\/\/doi.org\/10.1002\/mco2.127.","journal-title":"MedComm (Beijing)"},{"key":"819_CR45","doi-asserted-by":"publisher","first-page":"6439097","DOI":"10.1155\/2022\/6439097","volume":"2022","author":"M Huang","year":"2022","unstructured":"Huang M, Wu Q, Jiang Z-H. Epigenetic alterations under oxidative stress in stem cells. Oxid Med Cell Longev. 2022;2022:6439097. https:\/\/doi.org\/10.1155\/2022\/6439097.","journal-title":"Oxid Med Cell Longev"},{"key":"819_CR46","doi-asserted-by":"publisher","unstructured":"Sinenko SA, Starkova TYu, Kuzmin AA, Tomilin AN. Physiological signaling functions of reactive oxygen species in stem cells: from flies to man. Front Cell Dev Biol. 2021;9. https:\/\/doi.org\/10.3389\/fcell.2021.714370","DOI":"10.3389\/fcell.2021.714370"},{"key":"819_CR47","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1085\/jgp.201210772","volume":"139","author":"MA Aon","year":"2012","unstructured":"Aon MA, Stanley BA, Sivakumaran V, Kembro JM, O\u2019Rourke B, Paolocci N, et al. Glutathione\/thioredoxin systems modulate mitochondrial H2O2 emission: an experimental-computational study. J Gen Physiol. 2012;139:479\u201391. https:\/\/doi.org\/10.1085\/jgp.201210772.","journal-title":"J Gen Physiol"},{"key":"819_CR48","doi-asserted-by":"publisher","first-page":"33669","DOI":"10.1074\/jbc.M111.284612","volume":"286","author":"BA Stanley","year":"2011","unstructured":"Stanley BA, Sivakumaran V, Shi S, McDonald I, Lloyd D, Watson WH, et al. Thioredoxin reductase-2 is essential for keeping low levels of H(2)O(2) emission from isolated heart mitochondria. J Biol Chem. 2011;286:33669\u201377. https:\/\/doi.org\/10.1074\/jbc.M111.284612.","journal-title":"J Biol Chem"},{"key":"819_CR49","doi-asserted-by":"publisher","first-page":"37361","DOI":"10.1074\/jbc.M604123200","volume":"281","author":"LE Meyer","year":"2006","unstructured":"Meyer LE, Machado LB, Santiago APSA, da-Silva WS, De Felice FG, Holub O, et al. Mitochondrial creatine kinase activity prevents reactive oxygen species generation: antioxidant role of mitochondrial kinase-dependent ADP re-cycling activity. J Biol Chem. 2006;281:37361\u201371. https:\/\/doi.org\/10.1074\/jbc.M604123200.","journal-title":"J Biol Chem"},{"key":"819_CR50","doi-asserted-by":"publisher","first-page":"696","DOI":"10.3390\/antiox14060696","volume":"14","author":"ZZ Chong","year":"2025","unstructured":"Chong ZZ, Souayah N. Oxidative stress: pathological driver in chronic neurodegenerative diseases. Antioxidants. 2025;14:696. https:\/\/doi.org\/10.3390\/antiox14060696.","journal-title":"Antioxidants"},{"key":"819_CR51","doi-asserted-by":"publisher","first-page":"102667","DOI":"10.1016\/j.arr.2025.102667","volume":"104","author":"P Wen","year":"2025","unstructured":"Wen P, Sun Z, Gou F, Wang J, Fan Q, Zhao D, et al. Oxidative stress and mitochondrial impairment: key drivers in neurodegenerative disorders. Ageing Res Rev. 2025;104:102667. https:\/\/doi.org\/10.1016\/j.arr.2025.102667.","journal-title":"Ageing Res Rev"},{"key":"819_CR52","doi-asserted-by":"publisher","first-page":"1207","DOI":"10.3390\/cells14151207","volume":"14","author":"M Nigam","year":"2025","unstructured":"Nigam M, Punia B, Dimri DB, Mishra AP, Radu A-F, Bungau G. Reactive oxygen species: A Double-Edged sword in the modulation of cancer signaling pathway dynamics. Cells. 2025;14:1207. https:\/\/doi.org\/10.3390\/cells14151207.","journal-title":"Cells"},{"key":"819_CR53","doi-asserted-by":"publisher","first-page":"1659","DOI":"10.3390\/jcm8101659","volume":"8","author":"R Teleanu","year":"2019","unstructured":"Teleanu R, Chircov C, Grumezescu A, Volceanov A, Teleanu D. Antioxidant therapies for Neuroprotection\u2014A review. J Clin Med. 2019;8:1659. https:\/\/doi.org\/10.3390\/jcm8101659.","journal-title":"J Clin Med"},{"key":"819_CR54","doi-asserted-by":"publisher","first-page":"265","DOI":"10.3390\/ijms18020265","volume":"18","author":"O Arteaga","year":"2017","unstructured":"Arteaga O, \u00c1lvarez A, Revuelta M, Santaolalla F, Urtasun A, Hilario E. Role of antioxidants in neonatal Hypoxic\u2013Ischemic brain injury: new therapeutic approaches. Int J Mol Sci. 2017;18:265. https:\/\/doi.org\/10.3390\/ijms18020265.","journal-title":"Int J Mol Sci"},{"key":"819_CR55","doi-asserted-by":"publisher","first-page":"948889","DOI":"10.3389\/fphar.2022.948889","volume":"13","author":"Q Wang","year":"2022","unstructured":"Wang Q, Yu Q, Wu M. Antioxidant and neuroprotective actions of Resveratrol in cerebrovascular diseases. Front Pharmacol. 2022;13:948889. https:\/\/doi.org\/10.3389\/fphar.2022.948889.","journal-title":"Front Pharmacol"},{"key":"819_CR56","doi-asserted-by":"publisher","first-page":"73","DOI":"10.3892\/mmr.2020.11711","volume":"23","author":"M Ye","year":"2020","unstructured":"Ye M, Wu H, Li S. Resveratrol alleviates oxygen\/glucose deprivation\/reoxygenation-induced neuronal damage through induction of mitophagy. Mol Med Rep. 2020;23:73. https:\/\/doi.org\/10.3892\/mmr.2020.11711.","journal-title":"Mol Med Rep"},{"key":"819_CR57","first-page":"151","volume":"22","author":"GO Kavas","year":"2013","unstructured":"Kavas GO, Ayral PA, Elhan AH. The effects of Resveratrol on oxidant\/antioxidant systems and their cofactors in rats. Adv Clin Exp Med. 2013;22:151\u20135.","journal-title":"Adv Clin Exp Med"},{"key":"819_CR58","doi-asserted-by":"publisher","first-page":"26216","DOI":"10.1038\/s41598-024-76825-9","volume":"14","author":"S Wu","year":"2024","unstructured":"Wu S, Wang L, Wang F, Zhang J. Resveratrol improved mitochondrial biogenesis by activating SIRT1\/PGC-1\u03b1 signal pathway in SAP. Sci Rep. 2024;14:26216. https:\/\/doi.org\/10.1038\/s41598-024-76825-9.","journal-title":"Sci Rep"},{"key":"819_CR59","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1186\/s40104-022-00822-z","volume":"14","author":"Q Meng","year":"2023","unstructured":"Meng Q, Li J, Wang C, Shan A. Biological function of Resveratrol and its application in animal production: a review. J Anim Sci Biotechnol. 2023;14:25. https:\/\/doi.org\/10.1186\/s40104-022-00822-z.","journal-title":"J Anim Sci Biotechnol"},{"key":"819_CR60","doi-asserted-by":"publisher","first-page":"112164","DOI":"10.1016\/j.biopha.2021.112164","volume":"143","author":"L-X Zhang","year":"2021","unstructured":"Zhang L-X, Li C-X, Kakar MU, Khan MS, Wu P-F, Amir RM, et al. Resveratrol (RV): A Pharmacological review and call for further research. Biomed Pharmacother. 2021;143:112164. https:\/\/doi.org\/10.1016\/j.biopha.2021.112164.","journal-title":"Biomed Pharmacother"},{"key":"819_CR61","doi-asserted-by":"publisher","first-page":"20209","DOI":"10.1039\/c3ra42923g","volume":"3","author":"M Cordova-Gomez","year":"2013","unstructured":"Cordova-Gomez M, Galano A, Alvarez-Idaboy JR. Piceatannol, a better Peroxyl radical scavenger than Resveratrol. RSC Adv. 2013;3:20209. https:\/\/doi.org\/10.1039\/c3ra42923g.","journal-title":"RSC Adv"},{"key":"819_CR62","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1038\/sj.bjp.0702357","volume":"126","author":"S Tsai","year":"1999","unstructured":"Tsai S, Lin-Shiau S, Lin J. Suppression of nitric oxide synthase and the down\u2010regulation of the activation of NF\u03baB in macrophages by Resveratrol. Br J Pharmacol. 1999;126:673\u201380. https:\/\/doi.org\/10.1038\/sj.bjp.0702357.","journal-title":"Br J Pharmacol"},{"key":"819_CR63","doi-asserted-by":"publisher","unstructured":"Bartra C, Yuan Y, Vurai\u0107 K, Vald\u00e9s-Quiroz H, Garcia-Baucells P, Slevin M, et al. Resveratrol activates antioxidant protective mechanisms in cellular models of Alzheimer\u2019s disease inflammation. Antioxid (Basel). 2024;13. https:\/\/doi.org\/10.3390\/antiox13020177.","DOI":"10.3390\/antiox13020177"},{"key":"819_CR64","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1007\/s11064-006-9255-z","volume":"32","author":"M Mokni","year":"2007","unstructured":"Mokni M, Elkahoui S, Limam F, Amri M, Aouani E. Effect of Resveratrol on antioxidant enzyme activities in the brain of healthy rat. Neurochem Res. 2007;32:981\u20137. https:\/\/doi.org\/10.1007\/s11064-006-9255-z.","journal-title":"Neurochem Res"},{"key":"819_CR65","doi-asserted-by":"publisher","first-page":"149","DOI":"10.3233\/JAD-210132","volume":"82","author":"F Ye","year":"2021","unstructured":"Ye F, Wu A. The protective mechanism of SIRT1 in the regulation of mitochondrial biogenesis and mitochondrial autophagy in alzheimer\u2019s disease. J Alzheimer\u2019s Disease. 2021;82:149\u201357. https:\/\/doi.org\/10.3233\/JAD-210132.","journal-title":"J Alzheimer\u2019s Disease"},{"key":"819_CR66","doi-asserted-by":"publisher","unstructured":"Kincaid B, Bossy-Wetzel E. Forever young: SIRT3 a shield against mitochondrial meltdown, aging, and neurodegeneration. Front Aging Neurosci. 2013;5. https:\/\/doi.org\/10.3389\/fnagi.2013.00048.","DOI":"10.3389\/fnagi.2013.00048"},{"key":"819_CR67","doi-asserted-by":"publisher","first-page":"110234","DOI":"10.1016\/j.biopha.2020.110234","volume":"127","author":"T Farkhondeh","year":"2020","unstructured":"Farkhondeh T, Folgado SL, Pourbagher-Shahri AM, Ashrafizadeh M, Samarghandian S. The therapeutic effect of resveratrol: focusing on the Nrf2 signaling pathway. Biomed Pharmacother. 2020;127:110234. https:\/\/doi.org\/10.1016\/j.biopha.2020.110234.","journal-title":"Biomed Pharmacother"},{"key":"819_CR68","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1016\/j.ejpb.2015.04.002","volume":"93","author":"\u0160 Zupan\u010di\u010d","year":"2015","unstructured":"Zupan\u010di\u010d \u0160, Lavri\u010d Z, Kristl J. Stability and solubility of trans-resveratrol are strongly influenced by pH and temperature. Eur J Pharm Biopharm. 2015;93:196\u2013204. https:\/\/doi.org\/10.1016\/j.ejpb.2015.04.002.","journal-title":"Eur J Pharm Biopharm"},{"key":"819_CR69","doi-asserted-by":"publisher","unstructured":"Ji S-B, Park S-Y, Bae S, Seo H-J, Kim S-E, Lee G-M, et al. Comprehensive investigation of stereoselective food drug interaction potential of resveratrol on nine P450 and six UGT isoforms in human liver microsomes. Pharmaceutics. 2021;13. https:\/\/doi.org\/10.3390\/pharmaceutics13091419.","DOI":"10.3390\/pharmaceutics13091419"},{"key":"819_CR70","doi-asserted-by":"publisher","unstructured":"Sharifi-Rad J, Quispe C, Mukazhanova Z, Knut E, Turgumbayeva A, Kipchakbayeva A, et al. Resveratrol-based nanoformulations as an emerging therapeutic strategy for cancer. Front Mol Biosci. 2021;8. https:\/\/doi.org\/10.3389\/fmolb.2021.649395","DOI":"10.3389\/fmolb.2021.649395"},{"key":"819_CR71","doi-asserted-by":"publisher","unstructured":"Li C, Wang Z, Lei H, Zhang D. Recent progress in nanotechnology-based drug carriers for resveratrol delivery. Drug Deliv. 2023;30. https:\/\/doi.org\/10.1080\/10717544.2023.2174206.","DOI":"10.1080\/10717544.2023.2174206"},{"key":"819_CR72","doi-asserted-by":"publisher","first-page":"1138","DOI":"10.1007\/s13311-023-01378-0","volume":"20","author":"E Shamsher","year":"2023","unstructured":"Shamsher E, Khan RS, Davis BM, Dine K, Luong V, Somavarapu S, et al. Nanoparticles enhance solubility and neuroprotective effects of Resveratrol in demyelinating disease. Neurotherapeutics. 2023;20:1138\u201353. https:\/\/doi.org\/10.1007\/s13311-023-01378-0.","journal-title":"Neurotherapeutics"},{"key":"819_CR73","doi-asserted-by":"publisher","first-page":"1383","DOI":"10.1212\/WNL.0000000000002035","volume":"85","author":"RS Turner","year":"2015","unstructured":"Turner RS, Thomas RG, Craft S, van Dyck CH, Mintzer J, Reynolds BA, et al. A randomized, double-blind, placebo-controlled trial of Resveratrol for alzheimer disease. Neurology. 2015;85:1383\u201391. https:\/\/doi.org\/10.1212\/WNL.0000000000002035.","journal-title":"Neurology"},{"key":"819_CR74","doi-asserted-by":"publisher","first-page":"2698","DOI":"10.1089\/neu.2021.0057","volume":"38","author":"AA Vijayakumari","year":"2021","unstructured":"Vijayakumari AA, Parker D, Osmanlioglu Y, Alappatt JA, Whyte J, Diaz-Arrastia R, et al. Free water volume fraction: an imaging biomarker to characterize Moderate-to-Severe traumatic brain injury. J Neurotrauma. 2021;38:2698\u2013705. https:\/\/doi.org\/10.1089\/neu.2021.0057.","journal-title":"J Neurotrauma"},{"key":"819_CR75","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1007\/s00018-023-05073-3","volume":"81","author":"SV Okar","year":"2024","unstructured":"Okar SV, Fagiani F, Absinta M, Reich DS. Imaging of brain barrier inflammation and brain fluid drainage in human neurological diseases. Cell Mol Life Sci. 2024;81:31. https:\/\/doi.org\/10.1007\/s00018-023-05073-3.","journal-title":"Cell Mol Life Sci"},{"key":"819_CR76","doi-asserted-by":"publisher","first-page":"26901","DOI":"10.1038\/s41598-024-78246-0","volume":"14","author":"D Yoshimaru","year":"2024","unstructured":"Yoshimaru D, Tsurugizawa T, Hayashi N, Hata J, Shibukawa S, Hagiya K, et al. Relationship between regional volume changes and water diffusion in fixed marmoset brains: an in vivo and ex vivo comparison. Sci Rep. 2024;14:26901. https:\/\/doi.org\/10.1038\/s41598-024-78246-0.","journal-title":"Sci Rep"},{"key":"819_CR77","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1186\/s12986-024-00792-1","volume":"21","author":"A Azargoonjahromi","year":"2024","unstructured":"Azargoonjahromi A, Abutalebian F. Unraveling the therapeutic efficacy of Resveratrol in alzheimer\u2019s disease: an umbrella review of systematic evidence. Nutr Metab (Lond). 2024;21:15. https:\/\/doi.org\/10.1186\/s12986-024-00792-1.","journal-title":"Nutr Metab (Lond)"},{"key":"819_CR78","doi-asserted-by":"publisher","first-page":"747","DOI":"10.3390\/ijms25020747","volume":"25","author":"K Brown","year":"2024","unstructured":"Brown K, Theofanous D, Britton RG, Aburido G, Pepper C, Sri Undru S, et al. Resveratrol for the management of human health: how Far have we come? A systematic review of Resveratrol clinical trials to highlight gaps and opportunities. Int J Mol Sci. 2024;25:747. https:\/\/doi.org\/10.3390\/ijms25020747.","journal-title":"Int J Mol Sci"},{"key":"819_CR79","doi-asserted-by":"publisher","unstructured":"Gu W, Geng J, Zhao H, Li X, Song G. Effects of resveratrol on metabolic indicators in patients with type 2 diabetes: a systematic review and meta-analysis. Int J Clin Pract. 2022;2022. https:\/\/doi.org\/10.1155\/2022\/9734738.","DOI":"10.1155\/2022\/9734738"},{"key":"819_CR80","doi-asserted-by":"publisher","first-page":"225","DOI":"10.3390\/endocrines5020016","volume":"5","author":"GC Batista-Jorge","year":"2024","unstructured":"Batista-Jorge GC, Barcala-Jorge AS, Lelis DF, Santos DE, Jorge AH, Monteiro-Junior RS, et al. Resveratrol effects on metabolic syndrome features: a systematic review and Meta-Analysis. Endocrines. 2024;5:225\u201343. https:\/\/doi.org\/10.3390\/endocrines5020016.","journal-title":"Endocrines"},{"key":"819_CR81","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1016\/j.cmet.2015.02.009","volume":"21","author":"C Lee","year":"2015","unstructured":"Lee C, Zeng J, Drew BG, Sallam T, Martin-Montalvo A, Wan J, et al. The Mitochondrial-Derived peptide MOTS-c promotes metabolic homeostasis and reduces obesity and insulin resistance. Cell Metab. 2015;21:443\u201354. https:\/\/doi.org\/10.1016\/j.cmet.2015.02.009.","journal-title":"Cell Metab"},{"key":"819_CR82","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1016\/j.cmet.2018.06.008","volume":"28","author":"KH Kim","year":"2018","unstructured":"Kim KH, Son JM, Benayoun BA, Lee C. The Mitochondrial-Encoded peptide MOTS-c translocates to the nucleus to regulate nuclear gene expression in response to metabolic stress. Cell Metab. 2018;28:516\u2013e5247. https:\/\/doi.org\/10.1016\/j.cmet.2018.06.008.","journal-title":"Cell Metab"},{"key":"819_CR83","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1186\/s12967-023-03885-2","volume":"21","author":"W Wan","year":"2023","unstructured":"Wan W, Zhang L, Lin Y, Rao X, Wang X, Hua F, et al. Mitochondria-derived peptide MOTS-c: effects and mechanisms related to stress, metabolism and aging. J Transl Med. 2023;21:36. https:\/\/doi.org\/10.1186\/s12967-023-03885-2.","journal-title":"J Transl Med"},{"key":"819_CR84","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1038\/s41467-020-20790-0","volume":"12","author":"JC Reynolds","year":"2021","unstructured":"Reynolds JC, Lai RW, Woodhead JST, Joly JH, Mitchell CJ, Cameron-Smith D, et al. MOTS-c is an exercise-induced mitochondrial-encoded regulator of age-dependent physical decline and muscle homeostasis. Nat Commun. 2021;12:470. https:\/\/doi.org\/10.1038\/s41467-020-20790-0.","journal-title":"Nat Commun"},{"key":"819_CR85","doi-asserted-by":"publisher","first-page":"166126","DOI":"10.1016\/j.bbadis.2021.166126","volume":"1867","author":"B Yang","year":"2021","unstructured":"Yang B, Yu Q, Chang B, Guo Q, Xu S, Yi X, et al. MOTS-c interacts synergistically with exercise intervention to regulate PGC-1\u03b1 expression, attenuate insulin resistance and enhance glucose metabolism in mice via AMPK signaling pathway. Biochim Biophys Acta Mol Basis Dis. 2021;1867:166126. https:\/\/doi.org\/10.1016\/j.bbadis.2021.166126.","journal-title":"Biochim Biophys Acta Mol Basis Dis"},{"key":"819_CR86","doi-asserted-by":"publisher","first-page":"104381","DOI":"10.1016\/j.phrs.2019.104381","volume":"147","author":"Z Yan","year":"2019","unstructured":"Yan Z, Zhu S, Wang H, Wang L, Du T, Ye Z, et al. MOTS-c inhibits osteolysis in the mouse calvaria by affecting osteocyte-osteoclast crosstalk and inhibiting inflammation. Pharmacol Res. 2019;147:104381. https:\/\/doi.org\/10.1016\/j.phrs.2019.104381.","journal-title":"Pharmacol Res"},{"key":"819_CR87","doi-asserted-by":"publisher","first-page":"613","DOI":"10.3390\/antiox13050613","volume":"13","author":"Y Zhang","year":"2024","unstructured":"Zhang Y, Huang J, Zhang Y, Jiang F, Li S, He S, et al. The Mitochondrial-Derived peptide MOTS-c alleviates radiation pneumonitis via an Nrf2-Dependent mechanism. Antioxidants. 2024;13:613. https:\/\/doi.org\/10.3390\/antiox13050613.","journal-title":"Antioxidants"},{"key":"819_CR88","doi-asserted-by":"publisher","first-page":"5915","DOI":"10.1007\/s12035-023-03443-3","volume":"60","author":"J Xiao","year":"2023","unstructured":"Xiao J, Zhang Q, Shan Y, Ye F, Zhang X, Cheng J, et al. The Mitochondrial-Derived peptide (MOTS-c) interacted with Nrf2 to defend the antioxidant system to protect dopaminergic neurons against rotenone exposure. Mol Neurobiol. 2023;60:5915\u201330. https:\/\/doi.org\/10.1007\/s12035-023-03443-3.","journal-title":"Mol Neurobiol"},{"key":"819_CR89","doi-asserted-by":"publisher","first-page":"1506","DOI":"10.1021\/acschemneuro.0c00782","volume":"12","author":"J Jiang","year":"2021","unstructured":"Jiang J, Chang X, Nie Y, Shen Y, Liang X, Peng Y, et al. Peripheral administration of a Cell-Penetrating MOTS-c analogue enhances memory and attenuates A\u03b21-42- or LPS-Induced memory impairment through inhibiting neuroinflammation. ACS Chem Neurosci. 2021;12:1506\u201318. https:\/\/doi.org\/10.1021\/acschemneuro.0c00782.","journal-title":"ACS Chem Neurosci"},{"key":"819_CR90","doi-asserted-by":"publisher","first-page":"2362","DOI":"10.1021\/acschemneuro.3c00140","volume":"14","author":"J Jiang","year":"2023","unstructured":"Jiang J, Xu L, Yang L, Liu S, Wang Z. Mitochondrial-Derived peptide MOTS-c ameliorates spared nerve Injury-Induced neuropathic pain in mice by inhibiting microglia activation and neuronal oxidative damage in the spinal cord via the AMPK pathway. ACS Chem Neurosci. 2023;14:2362\u201374. https:\/\/doi.org\/10.1021\/acschemneuro.3c00140.","journal-title":"ACS Chem Neurosci"},{"key":"819_CR91","doi-asserted-by":"publisher","unstructured":"Rosito M, Testi C, Parisi G, Cortese B, Baiocco P, Di Angelantonio S. Exploring the use of dimethyl fumarate as microglia modulator for neurodegenerative diseases treatment. Antioxidants (Basel). 2020;9. https:\/\/doi.org\/10.3390\/antiox9080700.","DOI":"10.3390\/antiox9080700"},{"key":"819_CR92","doi-asserted-by":"publisher","unstructured":"Alart JA, \u00c1lvarez A, Catalan A, de la Herrero B, Alonso-Alconada D. Dimethyl fumarate strongly ameliorates Gray and white matter brain injury and modulates glial activation after severe Hypoxia-Ischemia in neonatal rats. Antioxidants (Basel). 2024;13. https:\/\/doi.org\/10.3390\/antiox13091122.","DOI":"10.3390\/antiox13091122"},{"key":"819_CR93","doi-asserted-by":"publisher","unstructured":"Bresciani G, Manai F, Davinelli S, Tucci P, Saso L, Amadio M. Novel potential pharmacological applications of dimethyl fumarate\u2014an overview and update. Front Pharmacol. 2023;14. https:\/\/doi.org\/10.3389\/fphar.2023.1264842.","DOI":"10.3389\/fphar.2023.1264842"},{"key":"819_CR94","doi-asserted-by":"publisher","first-page":"497","DOI":"10.3390\/ph15050497","volume":"15","author":"SD Thomas","year":"2022","unstructured":"Thomas SD, Jha NK, Sadek B, Ojha S. Repurposing dimethyl fumarate for cardiovascular diseases: pharmacological effects, molecular mechanisms, and therapeutic promise. Pharmaceuticals. 2022;15:497. https:\/\/doi.org\/10.3390\/ph15050497.","journal-title":"Pharmaceuticals"},{"key":"819_CR95","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1016\/j.freeradbiomed.2022.07.013","volume":"189","author":"N Esteras","year":"2022","unstructured":"Esteras N, Abramov AY. Nrf2 as a regulator of mitochondrial function: energy metabolism and beyond. Free Radic Biol Med. 2022;189:136\u201353. https:\/\/doi.org\/10.1016\/j.freeradbiomed.2022.07.013.","journal-title":"Free Radic Biol Med"},{"key":"819_CR96","doi-asserted-by":"publisher","first-page":"175025","DOI":"10.1016\/j.ejphar.2022.175025","volume":"926","author":"I Majkutewicz","year":"2022","unstructured":"Majkutewicz I. Dimethyl fumarate: A review of preclinical efficacy in models of neurodegenerative diseases. Eur J Pharmacol. 2022;926:175025. https:\/\/doi.org\/10.1016\/j.ejphar.2022.175025.","journal-title":"Eur J Pharmacol"},{"key":"819_CR97","doi-asserted-by":"publisher","unstructured":"Lee Y-S, Gupta DP, Park SH, Yang H-J, Song GJ. Anti-inflammatory effects of dimethyl fumarate in microglia via an autophagy dependent pathway. Front Pharmacol. 2021;12. https:\/\/doi.org\/10.3389\/fphar.2021.612981.","DOI":"10.3389\/fphar.2021.612981"},{"key":"819_CR98","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/j.expneurol.2015.02.022","volume":"266","author":"R Kunze","year":"2015","unstructured":"Kunze R, Urrutia A, Hoffmann A, Liu H, Helluy X, Pham M, et al. Dimethyl fumarate attenuates cerebral edema formation by protecting the blood\u2013brain barrier integrity. Exp Neurol. 2015;266:99\u2013111. https:\/\/doi.org\/10.1016\/j.expneurol.2015.02.022.","journal-title":"Exp Neurol"},{"key":"819_CR99","doi-asserted-by":"publisher","first-page":"4229","DOI":"10.3390\/ijms21124229","volume":"21","author":"KMA De Kleijn","year":"2020","unstructured":"De Kleijn KMA, Martens GJM. Molecular effects of FDA-Approved multiple sclerosis drugs on glial cells and neurons of the central nervous system. Int J Mol Sci. 2020;21:4229. https:\/\/doi.org\/10.3390\/ijms21124229.","journal-title":"Int J Mol Sci"},{"key":"819_CR100","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1177\/1352458520937282","volume":"27","author":"EE Longbrake","year":"2021","unstructured":"Longbrake EE, Mao-Draayer Y, Cascione M, Zielinski T, Bame E, Brassat D, et al. Dimethyl fumarate treatment shifts the immune environment toward an anti-inflammatory cell profile while maintaining protective humoral immunity. Multiple Scler J. 2021;27:883\u201394. https:\/\/doi.org\/10.1177\/1352458520937282.","journal-title":"Multiple Scler J"},{"key":"819_CR101","doi-asserted-by":"publisher","unstructured":"Gold R, Barnett M, Chan A, Feng H, Fujihara K, Giovannoni G, et al. Clinical use of dimethyl fumarate in multiple sclerosis treatment: an update to include China, using a modified Delphi method. Ther Adv Neurol Disord. 2023;16. https:\/\/doi.org\/10.1177\/17562864231180734.","DOI":"10.1177\/17562864231180734"},{"key":"819_CR102","unstructured":"Medicines and Healthcare products Regulatory Agency. Dimethyl fumarate (Tecfidera): updated advice on the risk of progressive multifocal leukoencephalopathy (PML) associated with mild lymphopenia. Drug Saf. 2021;14(6)."},{"key":"819_CR103","doi-asserted-by":"publisher","unstructured":"Lyons J, Hughes R, McCarthy K, Everage N, Kapadia S, Miller C, et al. Progressive multifocal leukoencephalopathy outcomes in patients with multiple sclerosis treated with dimethyl fumarate. Mult Scler J Exp Transl Clin. 2022;8. https:\/\/doi.org\/10.1177\/20552173221132469.","DOI":"10.1177\/20552173221132469"},{"key":"819_CR104","doi-asserted-by":"publisher","first-page":"103492","DOI":"10.1016\/j.msard.2022.103492","volume":"58","author":"CH Wood","year":"2022","unstructured":"Wood CH, Robertson NP, Htet ZM, Tallantyre EC. Incidence of persistent lymphopenia in people with multiple sclerosis on dimethyl fumarate. Mult Scler Relat Disord. 2022;58:103492. https:\/\/doi.org\/10.1016\/j.msard.2022.103492.","journal-title":"Mult Scler Relat Disord"},{"key":"819_CR105","doi-asserted-by":"publisher","first-page":"640","DOI":"10.1177\/1352458520942201","volume":"27","author":"J Garcia","year":"2021","unstructured":"Garcia J, Hendel-Chavez H, De-Goer M-G, L\u2019Honneur AS, Dubessy AL, Taoufik Y, et al. Progressive multifocal leukoencephalopathy on dimethyl fumarate with preserved lymphocyte count but deep T-cells exhaustion. Multiple Scler J. 2021;27:640\u20134. https:\/\/doi.org\/10.1177\/1352458520942201.","journal-title":"Multiple Scler J"},{"key":"819_CR106","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1177\/1352458520949158","volume":"28","author":"AL Jordan","year":"2022","unstructured":"Jordan AL, Yang J, Fisher CJ, Racke MK, Mao-Draayer Y. Progressive multifocal leukoencephalopathy in dimethyl fumarate-treated multiple sclerosis patients. Multiple Scler J. 2022;28:7\u201315. https:\/\/doi.org\/10.1177\/1352458520949158.","journal-title":"Multiple Scler J"},{"key":"819_CR107","doi-asserted-by":"publisher","first-page":"103669","DOI":"10.1016\/j.msard.2022.103669","volume":"59","author":"S de la Sainz","year":"2022","unstructured":"de la Sainz S, Sabin Mu\u00f1oz J, de la Pilo B, Thuissard I, Andreu-V\u00e1zquez C, Gal\u00e1n S\u00e1nchez-Seco V, et al. Early predictive risk factors for dimethyl fumarate-associated lymphopenia in patients with multiple sclerosis. Mult Scler Relat Disord. 2022;59:103669. https:\/\/doi.org\/10.1016\/j.msard.2022.103669.","journal-title":"Mult Scler Relat Disord"},{"key":"819_CR108","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1016\/j.freeradbiomed.2007.03.024","volume":"43","author":"MG Traber","year":"2007","unstructured":"Traber MG, Atkinson J, Vitamin E. Antioxidant and nothing more. Free Radic Biol Med. 2007;43:4\u201315. https:\/\/doi.org\/10.1016\/j.freeradbiomed.2007.03.024.","journal-title":"Free Radic Biol Med"},{"key":"819_CR109","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1086\/301699","volume":"62","author":"L Cavalier","year":"1998","unstructured":"Cavalier L, Ouahchi K, Kayden HJ, Di Donato S, Reutenauer L, Mandel J-L, et al. Ataxia with isolated vitamin E deficiency: heterogeneity of mutations and phenotypic variability in a large number of families. Am J Hum Genet. 1998;62:301\u201310. https:\/\/doi.org\/10.1086\/301699.","journal-title":"Am J Hum Genet"},{"key":"819_CR110","doi-asserted-by":"publisher","first-page":"1204","DOI":"10.1093\/jn\/121.8.1204","volume":"121","author":"J-M Bourre","year":"1991","unstructured":"Bourre J-M, Clement M. Kinetics of rat peripheral Nerve, forebrain and cerebellum \u03b1-Tocopherol depletion: comparison with different organs. J Nutr. 1991;121:1204\u20137. https:\/\/doi.org\/10.1093\/jn\/121.8.1204.","journal-title":"J Nutr"},{"key":"819_CR111","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/j.brainres.2008.01.044","volume":"1201","author":"K Gohil","year":"2008","unstructured":"Gohil K, Oommen S, Quach HT, Vasu VT, Aung HH, Schock B, et al. Mice lacking \u03b1-tocopherol transfer protein gene have severe \u03b1-tocopherol deficiency in multiple regions of the central nervous system. Brain Res. 2008;1201:167\u201376. https:\/\/doi.org\/10.1016\/j.brainres.2008.01.044.","journal-title":"Brain Res"},{"key":"819_CR112","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1016\/S0006-8993(99)01090-2","volume":"822","author":"RP Copp","year":"1999","unstructured":"Copp RP, Wisniewski T, Hentati F, Larnaout A, Ben Hamida M, Kayden HJ. Localization of \u03b1-tocopherol transfer protein in the brains of patients with ataxia with vitamin E deficiency and other oxidative stress related neurodegenerative disorders. Brain Res. 1999;822:80\u20137. https:\/\/doi.org\/10.1016\/S0006-8993(99)01090-2.","journal-title":"Brain Res"},{"key":"819_CR113","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1146\/annurev-nutr-071812-161252","volume":"33","author":"L Ulatowski","year":"2013","unstructured":"Ulatowski L, Manor D. Vitamin E trafficking in neurologic health and disease. Annu Rev Nutr. 2013;33:87\u2013103. https:\/\/doi.org\/10.1146\/annurev-nutr-071812-161252.","journal-title":"Annu Rev Nutr"},{"key":"819_CR114","doi-asserted-by":"publisher","first-page":"325","DOI":"10.5607\/en.2015.24.4.325","volume":"24","author":"GH Kim","year":"2015","unstructured":"Kim GH, Kim JE, Rhie SJ, Yoon S. The role of oxidative stress in neurodegenerative diseases. Exp Neurobiol. 2015;24:325\u201340. https:\/\/doi.org\/10.5607\/en.2015.24.4.325.","journal-title":"Exp Neurobiol"},{"key":"819_CR115","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1016\/j.freeradbiomed.2008.12.018","volume":"46","author":"FE Harrison","year":"2009","unstructured":"Harrison FE, May JM. Vitamin C function in the brain: vital role of the ascorbate transporter SVCT2. Free Radic Biol Med. 2009;46:719\u201330. https:\/\/doi.org\/10.1016\/j.freeradbiomed.2008.12.018.","journal-title":"Free Radic Biol Med"},{"key":"819_CR116","doi-asserted-by":"publisher","unstructured":"Sommer A, Vyas KS. A global clinical view on vitamin A and carotenoids. Am J Clin Nutr. 2012;96:1204S\u20131206S. https:\/\/doi.org\/10.3945\/ajcn.112.034868.","DOI":"10.3945\/ajcn.112.034868"},{"key":"819_CR117","doi-asserted-by":"publisher","unstructured":"Tanumihardjo SA, Vitamin A. Biomarkers of nutrition for development. Am J Clin Nutr. 2011;94:658S\u2013665S. https:\/\/doi.org\/10.3945\/ajcn.110.005777.","DOI":"10.3945\/ajcn.110.005777"},{"key":"819_CR118","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1006\/abbi.1993.1074","volume":"300","author":"GR Buettner","year":"1993","unstructured":"Buettner GR. The pecking order of free radicals and antioxidants: lipid Peroxidation, \u03b1-Tocopherol, and ascorbate. Arch Biochem Biophys. 1993;300:535\u201343. https:\/\/doi.org\/10.1006\/abbi.1993.1074.","journal-title":"Arch Biochem Biophys"},{"key":"819_CR119","doi-asserted-by":"publisher","first-page":"1141","DOI":"10.3390\/antiox12061141","volume":"12","author":"D Be\u0161lo","year":"2023","unstructured":"Be\u0161lo D, Golubi\u0107 N, Rastija V, Agi\u0107 D, Karna\u0161 M, \u0160ubari\u0107 D, et al. Antioxidant Activity, Metabolism, and bioavailability of polyphenols in the diet of animals. Antioxidants. 2023;12:1141. https:\/\/doi.org\/10.3390\/antiox12061141.","journal-title":"Antioxidants"},{"key":"819_CR120","doi-asserted-by":"publisher","first-page":"429","DOI":"10.3390\/antiox13040429","volume":"13","author":"M Rudrapal","year":"2024","unstructured":"Rudrapal M, Rakshit G, Singh RP, Garse S, Khan J, Chakraborty S. Dietary polyphenols: review on Chemistry\/Sources, Bioavailability\/Metabolism, antioxidant Effects, and their role in disease management. Antioxidants. 2024;13:429. https:\/\/doi.org\/10.3390\/antiox13040429.","journal-title":"Antioxidants"},{"key":"819_CR121","doi-asserted-by":"publisher","first-page":"472","DOI":"10.3390\/antiox3030472","volume":"3","author":"R Shirley","year":"2014","unstructured":"Shirley R, Ord E, Work L. Oxidative stress and the use of antioxidants in stroke. Antioxidants. 2014;3:472\u2013501. https:\/\/doi.org\/10.3390\/antiox3030472.","journal-title":"Antioxidants"},{"key":"819_CR122","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2020\/6687185","volume":"2020","author":"N Yang","year":"2020","unstructured":"Yang N, Guan Q-W, Chen F-H, Xia Q-X, Yin X-X, Zhou H-H, et al. Antioxidants targeting mitochondrial oxidative stress: promising neuroprotectants for epilepsy. Oxid Med Cell Longev. 2020;2020:1\u201314. https:\/\/doi.org\/10.1155\/2020\/6687185.","journal-title":"Oxid Med Cell Longev"},{"key":"819_CR123","doi-asserted-by":"publisher","first-page":"3010","DOI":"10.3390\/biomedicines11113010","volume":"11","author":"S Salatin","year":"2023","unstructured":"Salatin S, Farhoudi M, Farjami A, Maleki Dizaj S, Sharifi S, Shahi S. Nanoparticle formulations of antioxidants for the management of oxidative stress in stroke: A review. Biomedicines. 2023;11:3010. https:\/\/doi.org\/10.3390\/biomedicines11113010.","journal-title":"Biomedicines"},{"key":"819_CR124","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1186\/s40779-023-00482-8","volume":"10","author":"S Hao","year":"2023","unstructured":"Hao S, Huang H, Ma R-Y, Zeng X, Duan C-Y. Multifaceted functions of Drp1 in hypoxia\/ischemia-induced mitochondrial quality imbalance: from regulatory mechanism to targeted therapeutic strategy. Mil Med Res. 2023;10:46. https:\/\/doi.org\/10.1186\/s40779-023-00482-8.","journal-title":"Mil Med Res"},{"key":"819_CR125","doi-asserted-by":"publisher","unstructured":"Mitroshina EV, Savyuk MO, Ponimaskin E, Vedunova MV. Hypoxia-inducible factor (HIF) in ischemic stroke and neurodegenerative disease. Front Cell Dev Biol. 2021;9. https:\/\/doi.org\/10.3389\/fcell.2021.703084","DOI":"10.3389\/fcell.2021.703084"},{"key":"819_CR126","doi-asserted-by":"publisher","unstructured":"He Q, Ma Y, Liu J, Zhang D, Ren J, Zhao R, et al. Biological functions and regulatory mechanisms of hypoxia-inducible factor-1\u03b1 in ischemic stroke. Front Immunol. 2021;12. https:\/\/doi.org\/10.3389\/fimmu.2021.801985.","DOI":"10.3389\/fimmu.2021.801985"},{"key":"819_CR127","doi-asserted-by":"publisher","first-page":"41","DOI":"10.3892\/mmr.2021.12557","volume":"25","author":"P Dong","year":"2021","unstructured":"Dong P, Li Q, Han H. HIF-1\u03b1 in cerebral ischemia (Review). Mol Med Rep. 2021;25:41. https:\/\/doi.org\/10.3892\/mmr.2021.12557.","journal-title":"Mol Med Rep"},{"key":"819_CR128","doi-asserted-by":"publisher","unstructured":"Li K, Zheng Y, Wang X. The potential relationship between HIF-1\u03b1 and amino acid metabolism after hypoxic ischemia and dual effects on neurons. Front Neurosci. 2021;15. https:\/\/doi.org\/10.3389\/fnins.2021.676553.","DOI":"10.3389\/fnins.2021.676553"},{"key":"819_CR129","doi-asserted-by":"publisher","first-page":"924","DOI":"10.14336\/AD.2017.1126","volume":"9","author":"F Liu","year":"2018","unstructured":"Liu F, Lu J, Manaenko A, Tang J, Hu Q. Mitochondria in ischemic stroke: new insight and implications. Aging Dis. 2018;9:924\u201337. https:\/\/doi.org\/10.14336\/AD.2017.1126.","journal-title":"Aging Dis"},{"key":"819_CR130","doi-asserted-by":"publisher","first-page":"352","DOI":"10.3389\/fphar.2020.00352","volume":"11","author":"Y Li","year":"2020","unstructured":"Li Y, Sun J, Wu R, Bai J, Hou Y, Zeng Y, et al. Mitochondrial MPTP: a novel target of ethnomedicine for stroke treatment by apoptosis Inhibition. Front Pharmacol. 2020;11:352. https:\/\/doi.org\/10.3389\/fphar.2020.00352.","journal-title":"Front Pharmacol"},{"key":"819_CR131","doi-asserted-by":"publisher","first-page":"281","DOI":"10.3389\/fncel.2014.00281","volume":"8","author":"U Anilkumar","year":"2014","unstructured":"Anilkumar U, Prehn JHM. Anti-apoptotic BCL-2 family proteins in acute neural injury. Front Cell Neurosci. 2014;8:281. https:\/\/doi.org\/10.3389\/fncel.2014.00281.","journal-title":"Front Cell Neurosci"},{"key":"819_CR132","doi-asserted-by":"publisher","first-page":"1141","DOI":"10.1177\/0883073809338212","volume":"24","author":"H Hagberg","year":"2009","unstructured":"Hagberg H, Mallard C, Rousset CI, Xiaoyang W. Apoptotic mechanisms in the immature brain: involvement of mitochondria. J Child Neurol. 2009;24:1141\u20136. https:\/\/doi.org\/10.1177\/0883073809338212.","journal-title":"J Child Neurol"},{"key":"819_CR133","doi-asserted-by":"publisher","first-page":"121","DOI":"10.3325\/cmj.2019.60.121","volume":"60","author":"V Hribljan","year":"2019","unstructured":"Hribljan V, Lisjak D, Petrovi\u0107 DJ, Mitre\u010di\u0107 D. Necroptosis is one of the modalities of cell death accompanying ischemic brain stroke: from pathogenesis to therapeutic possibilities. Croat Med J. 2019;60:121\u20136. https:\/\/doi.org\/10.3325\/cmj.2019.60.121.","journal-title":"Croat Med J"},{"key":"819_CR134","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1038\/s41418-018-0212-6","volume":"26","author":"D Frank","year":"2019","unstructured":"Frank D, Vince JE. Pyroptosis versus necroptosis: similarities, differences, and crosstalk. Cell Death Differ. 2019;26:99\u2013114. https:\/\/doi.org\/10.1038\/s41418-018-0212-6.","journal-title":"Cell Death Differ"},{"key":"819_CR135","doi-asserted-by":"publisher","first-page":"832356","DOI":"10.3389\/fcell.2022.832356","volume":"10","author":"C Tian","year":"2022","unstructured":"Tian C, Liu Y, Li Z, Zhu P, Zhao M. Mitochondria related cell death modalities and disease. Front Cell Dev Biol. 2022;10:832356. https:\/\/doi.org\/10.3389\/fcell.2022.832356.","journal-title":"Front Cell Dev Biol"},{"key":"819_CR136","doi-asserted-by":"publisher","unstructured":"Li Y, Sun J, Wu R, Bai J, Hou Y, Zeng Y, et al. Mitochondrial MPTP: a novel target of ethnomedicine for stroke treatment by apoptosis inhibition. Front Pharmacol. 2020;11. https:\/\/doi.org\/10.3389\/fphar.2020.00352.","DOI":"10.3389\/fphar.2020.00352"},{"key":"819_CR137","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1016\/j.devcel.2011.08.008","volume":"21","author":"JR Hom","year":"2011","unstructured":"Hom JR, Quintanilla RA, Hoffman DL, de Mesy Bentley KL, Molkentin JD, Sheu S-S, et al. The permeability transition pore controls cardiac mitochondrial maturation and myocyte differentiation. Dev Cell. 2011;21:469\u201378. https:\/\/doi.org\/10.1016\/j.devcel.2011.08.008.","journal-title":"Dev Cell"},{"key":"819_CR138","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1089\/ars.2011.4459","volume":"18","author":"C Penna","year":"2013","unstructured":"Penna C, Perrelli M-G, Pagliaro P. Mitochondrial pathways, permeability transition pore, and redox signaling in cardioprotection: therapeutic implications. Antioxid Redox Signal. 2013;18:556\u201399. https:\/\/doi.org\/10.1089\/ars.2011.4459.","journal-title":"Antioxid Redox Signal"},{"key":"819_CR139","doi-asserted-by":"publisher","first-page":"497","DOI":"10.2967\/jnumed.111.089623","volume":"52","author":"R Watanabe","year":"2011","unstructured":"Watanabe R, Wei L, Huang J. mTOR Signaling, Function, novel Inhibitors, and therapeutic targets. J Nucl Med. 2011;52:497\u2013500. https:\/\/doi.org\/10.2967\/jnumed.111.089623.","journal-title":"J Nucl Med"},{"key":"819_CR140","doi-asserted-by":"publisher","first-page":"5590","DOI":"10.1523\/JNEUROSCI.0545-23.2023","volume":"43","author":"S Nemati","year":"2023","unstructured":"Nemati S, Kondiles BR, Wheeler S. The contributions of the mTOR complexes: how does regional and Temporal heterogeneity affect myelination and remyelination? J Neurosci. 2023;43:5590\u20132. https:\/\/doi.org\/10.1523\/JNEUROSCI.0545-23.2023.","journal-title":"J Neurosci"},{"key":"819_CR141","doi-asserted-by":"publisher","first-page":"1882","DOI":"10.1093\/advances\/nmac055","volume":"13","author":"G Wang","year":"2022","unstructured":"Wang G, Chen L, Qin S, Zhang T, Yao J, Yi Y, et al. Mechanistic target of Rapamycin complex 1: from a nutrient sensor to a key regulator of metabolism and health. Adv Nutr. 2022;13:1882\u2013900. https:\/\/doi.org\/10.1093\/advances\/nmac055.","journal-title":"Adv Nutr"},{"key":"819_CR142","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1042\/BCJ20220325","volume":"481","author":"A Ragupathi","year":"2024","unstructured":"Ragupathi A, Kim C, Jacinto E. The mTORC2 signaling network: targets and cross-talks. Biochem J. 2024;481:45\u201391. https:\/\/doi.org\/10.1042\/BCJ20220325.","journal-title":"Biochem J"},{"key":"819_CR143","doi-asserted-by":"publisher","first-page":"2893","DOI":"10.1101\/gad.1256804","volume":"18","author":"J Brugarolas","year":"2004","unstructured":"Brugarolas J, Lei K, Hurley RL, Manning BD, Reiling JH, Hafen E, et al. Regulation of mTOR function in response to hypoxia by REDD1 and the TSC1\/TSC2 tumor suppressor complex. Genes Dev. 2004;18:2893\u2013904. https:\/\/doi.org\/10.1101\/gad.1256804.","journal-title":"Genes Dev"},{"key":"819_CR144","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1016\/j.molcel.2010.10.030","volume":"40","author":"H Cam","year":"2010","unstructured":"Cam H, Easton JB, High A, Houghton PJ. mTORC1 signaling under hypoxic conditions is controlled by ATM-Dependent phosphorylation of HIF-1\u03b1. Mol Cell. 2010;40:509\u201320. https:\/\/doi.org\/10.1016\/j.molcel.2010.10.030.","journal-title":"Mol Cell"},{"key":"819_CR145","doi-asserted-by":"publisher","first-page":"37","DOI":"10.5604\/20828691.1198520","volume":"6","author":"A Kolasi\u0144ska-\u0106wik\u0142a","year":"2016","unstructured":"Kolasi\u0144ska-\u0106wik\u0142a A. The mTOR signalling pathways in the pathogenesis and treatment of neuroendocrine tumours. OncoReview. 2016;6:37\u201342. https:\/\/doi.org\/10.5604\/20828691.1198520.","journal-title":"OncoReview"},{"key":"819_CR146","doi-asserted-by":"publisher","unstructured":"Perez-Alvarez MJ, Villa Gonzalez M, Benito-Cuesta I, Wandosell FG. Role of mTORC1 controlling proteostasis after brain ischemia. Front Neurosci. 2018;12. https:\/\/doi.org\/10.3389\/fnins.2018.00060.","DOI":"10.3389\/fnins.2018.00060"},{"key":"819_CR147","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1186\/s13024-021-00428-5","volume":"16","author":"H Querfurth","year":"2021","unstructured":"Querfurth H, Lee H-K. Mammalian\/mechanistic target of Rapamycin (mTOR) complexes in neurodegeneration. Mol Neurodegener. 2021;16:44. https:\/\/doi.org\/10.1186\/s13024-021-00428-5.","journal-title":"Mol Neurodegener"},{"key":"819_CR148","doi-asserted-by":"publisher","unstructured":"Spilman P, Podlutskaya N, Hart MJ, Debnath J, Gorostiza O, Bredesen D, et al. Correction: inhibition of mTOR by Rapamycin abolishes cognitive deficits and reduces amyloid-\u03b2 levels in a mouse model of Alzheimer\u2019s disease. PLoS ONE. 2011;6. https:\/\/doi.org\/10.1371\/annotation\/05c1b976-7eab-4154-808d-0526e604b8eb.","DOI":"10.1371\/annotation\/05c1b976-7eab-4154-808d-0526e604b8eb"},{"key":"819_CR149","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1186\/s13041-024-01166-7","volume":"17","author":"Q Wang","year":"2024","unstructured":"Wang Q, Liu X, Yuan J, Yang T, Ding L, Song B, et al. Nek6 regulates autophagy through the mTOR signaling pathway to alleviate cerebral ischemia\u2013reperfusion injury. Mol Brain. 2024;17:96. https:\/\/doi.org\/10.1186\/s13041-024-01166-7.","journal-title":"Mol Brain"},{"key":"819_CR150","doi-asserted-by":"publisher","first-page":"974","DOI":"10.1186\/s12967-024-05780-w","volume":"22","author":"F Liu","year":"2024","unstructured":"Liu F, Lin X, Wu X, Sui X, Ren W, Wang Q, et al. The role of TRAP1 in regulating mitochondrial dynamics during acute hypoxia-induced brain injury. J Transl Med. 2024;22:974. https:\/\/doi.org\/10.1186\/s12967-024-05780-w.","journal-title":"J Transl Med"},{"key":"819_CR151","doi-asserted-by":"publisher","first-page":"1829","DOI":"10.3390\/antiox10111829","volume":"10","author":"I Ramos Rego","year":"2021","unstructured":"Ramos Rego I, Santos Cruz B, Ambr\u00f3sio AF, Alves CH. TRAP1 in oxidative stress and neurodegeneration. Antioxidants. 2021;10:1829. https:\/\/doi.org\/10.3390\/antiox10111829.","journal-title":"Antioxidants"},{"key":"819_CR152","doi-asserted-by":"publisher","first-page":"573","DOI":"10.3892\/ijo.2013.2199","volume":"44","author":"L SISINNI","year":"2014","unstructured":"SISINNI L, MADDALENA F, LETTINI G, CONDELLI V, MATASSA DS. TRAP1 role in Endoplasmic reticulum stress protection favors resistance to anthracyclins in breast carcinoma cells. Int J Oncol. 2014;44:573\u201382. https:\/\/doi.org\/10.3892\/ijo.2013.2199.","journal-title":"Int J Oncol"},{"key":"819_CR153","doi-asserted-by":"publisher","first-page":"648","DOI":"10.3390\/cells13070648","volume":"13","author":"AY Baev","year":"2024","unstructured":"Baev AY, Vinokurov AY, Potapova EV, Dunaev AV, Angelova PR, Abramov AY. Mitochondrial permeability Transition, cell death and neurodegeneration. Cells. 2024;13:648. https:\/\/doi.org\/10.3390\/cells13070648.","journal-title":"Cells"},{"key":"819_CR154","doi-asserted-by":"publisher","first-page":"e0273677","DOI":"10.1371\/journal.pone.0273677","volume":"17","author":"S Sosunov","year":"2022","unstructured":"Sosunov S, Bhutada A, Niatsetskaya Z, Starkov A, Ten V. Mitochondrial calcium buffering depends upon temperature and is associated with hypothermic neuroprotection against hypoxia-ischemia injury. PLoS ONE. 2022;17:e0273677. https:\/\/doi.org\/10.1371\/journal.pone.0273677.","journal-title":"PLoS ONE"},{"key":"819_CR155","doi-asserted-by":"publisher","first-page":"1273","DOI":"10.3390\/cells12091273","volume":"12","author":"R Endlicher","year":"2023","unstructured":"Endlicher R, Drahota Z, \u0160tefkov\u00e1 K, \u010cervinkov\u00e1 Z, Ku\u010dera O. The mitochondrial permeability transition Pore\u2014Current knowledge of its Structure, Function, and Regulation, and optimized methods for evaluating its functional state. Cells. 2023;12:1273. https:\/\/doi.org\/10.3390\/cells12091273.","journal-title":"Cells"},{"key":"819_CR156","doi-asserted-by":"publisher","first-page":"602","DOI":"10.1111\/cns.12546","volume":"22","author":"N Tajiri","year":"2016","unstructured":"Tajiri N, Borlongan CV, Kaneko Y, Cyclosporine A. Treatment abrogates Ischemia-Induced neuronal cell death by preserving mitochondrial integrity through upregulation of the parkinson\u2019s Disease\u2010Associated protein DJ\u20101. CNS Neurosci Ther. 2016;22:602\u201310. https:\/\/doi.org\/10.1111\/cns.12546.","journal-title":"CNS Neurosci Ther"},{"key":"819_CR157","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1007\/s00395-009-0004-8","volume":"104","author":"CP Baines","year":"2009","unstructured":"Baines CP. The mitochondrial permeability transition pore and ischemia-reperfusion injury. Basic Res Cardiol. 2009;104:181\u20138. https:\/\/doi.org\/10.1007\/s00395-009-0004-8.","journal-title":"Basic Res Cardiol"},{"key":"819_CR158","doi-asserted-by":"publisher","first-page":"e1105","DOI":"10.1038\/cddis.2014.80","volume":"5","author":"SY Kim","year":"2014","unstructured":"Kim SY, Shim MS, Kim K-Y, Weinreb RN, Wheeler LA, Ju W-K. Inhibition of Cyclophilin D by cyclosporin A promotes retinal ganglion cell survival by preventing mitochondrial alteration in ischemic injury. Cell Death Dis. 2014;5:e1105\u20131105. https:\/\/doi.org\/10.1038\/cddis.2014.80.","journal-title":"Cell Death Dis"},{"key":"819_CR159","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1007\/s12031-016-0843-3","volume":"61","author":"F Fakharnia","year":"2017","unstructured":"Fakharnia F, Khodagholi F, Dargahi L, Ahmadiani A. Prevention of cyclophilin D-mediated mPTP opening using cyclosporine-A alleviates the elevation of necroptosis, autophagy and apoptosis-related markers following global cerebral ischemia-reperfusion. J Mol Neurosci. 2017;61:52\u201360. https:\/\/doi.org\/10.1007\/s12031-016-0843-3.","journal-title":"J Mol Neurosci"},{"key":"819_CR160","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1186\/s12951-022-01474-x","volume":"20","author":"D Liu","year":"2022","unstructured":"Liu D, Ji Q, Cheng Y, Liu M, Zhang B, Mei Q, et al. Cyclosporine A loaded brain targeting nanoparticle to treat cerebral ischemia\/reperfusion injury in mice. J Nanobiotechnol. 2022;20:256. https:\/\/doi.org\/10.1186\/s12951-022-01474-x.","journal-title":"J Nanobiotechnol"},{"key":"819_CR161","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1016\/j.molbrainres.2003.11.006","volume":"121","author":"K Doma\u00f1ska-Janik","year":"2004","unstructured":"Doma\u00f1ska-Janik K, Buza\u00f1ska L, D\u0142uzniewska J, Koz\u0142owska H, Sarnowska A, Zab\u0142ocka B. Neuroprotection by cyclosporin A following transient brain ischemia correlates with the Inhibition of the early efflux of cytochrome C to cytoplasm. Brain Res Mol Brain Res. 2004;121:50\u20139. https:\/\/doi.org\/10.1016\/j.molbrainres.2003.11.006.","journal-title":"Brain Res Mol Brain Res"},{"key":"819_CR162","doi-asserted-by":"publisher","unstructured":"Xie Q, Zeng J, Zheng Y, Li T, Ren J, Chen K, et al. Mitochondrial transplantation attenuates cerebral ischemia-reperfusion injury: possible involvement of mitochondrial component separation. Oxid Med Cell Longev. 2021;2021. https:\/\/doi.org\/10.1155\/2021\/1006636.","DOI":"10.1155\/2021\/1006636"},{"key":"819_CR163","doi-asserted-by":"publisher","first-page":"1325","DOI":"10.4103\/1673-5374.385313","volume":"19","author":"L Sun","year":"2024","unstructured":"Sun L, Zhao Z, Guo J, Qin Y, Yu Q, Shi X, et al. Mitochondrial transplantation confers protection against the effects of ischemic stroke by repressing microglial pyroptosis and promoting neurogenesis. Neural Regen Res. 2024;19:1325\u201335. https:\/\/doi.org\/10.4103\/1673-5374.385313.","journal-title":"Neural Regen Res"},{"key":"819_CR164","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1186\/s12967-023-04203-6","volume":"21","author":"M Sun","year":"2023","unstructured":"Sun M, Jiang W, Mu N, Zhang Z, Yu L, Ma H. Mitochondrial transplantation as a novel therapeutic strategy for cardiovascular diseases. J Transl Med. 2023;21:347. https:\/\/doi.org\/10.1186\/s12967-023-04203-6.","journal-title":"J Transl Med"},{"key":"819_CR165","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2022\/1346343","volume":"2022","author":"T Chen","year":"2022","unstructured":"Chen T, Zhu Y, Jia J, Meng H, Xu C, Xian P, et al. Mitochondrial transplantation promotes remyelination and Long-Term locomotion recovery following cerebral ischemia. Mediators Inflamm. 2022;2022:1\u20138. https:\/\/doi.org\/10.1155\/2022\/1346343.","journal-title":"Mediators Inflamm"},{"key":"819_CR166","doi-asserted-by":"publisher","unstructured":"Zhou M, Zang J, Qian Y, Zhang Q, Wang Y, Yao T, et al. Mitochondrial transplantation via magnetically responsive artificial cells promotes intracerebral hemorrhage recovery by supporting microglia immunological homeostasis. Adv Mater. 2025;37. https:\/\/doi.org\/10.1002\/adma.202500303.","DOI":"10.1002\/adma.202500303"},{"key":"819_CR167","doi-asserted-by":"publisher","first-page":"105971","DOI":"10.1016\/j.neubiorev.2024.105971","volume":"169","author":"A Riou","year":"2025","unstructured":"Riou A, Broeglin A, Grimm A. Mitochondrial transplantation in brain disorders: Achievements, methods, and challenges. Neurosci Biobehav Rev. 2025;169:105971. https:\/\/doi.org\/10.1016\/j.neubiorev.2024.105971.","journal-title":"Neurosci Biobehav Rev"},{"key":"819_CR168","doi-asserted-by":"publisher","unstructured":"Wang X, Liu Z, Zhang L, Hu G, Tao L, Zhang F. Mitochondrial transplantation for the treatment of cardiac and noncardiac diseases: mechanisms, prospective, and challenges. Life Med. 2024;3. https:\/\/doi.org\/10.1093\/lifemedi\/lnae017.","DOI":"10.1093\/lifemedi\/lnae017"},{"key":"819_CR169","doi-asserted-by":"publisher","first-page":"6365","DOI":"10.3390\/ijms21176365","volume":"21","author":"Y Yamada","year":"2020","unstructured":"Yamada Y, Ito M, Arai M, Hibino M, Tsujioka T, Harashima H. Challenges in promoting mitochondrial transplantation therapy. Int J Mol Sci. 2020;21:6365. https:\/\/doi.org\/10.3390\/ijms21176365.","journal-title":"Int J Mol Sci"},{"key":"819_CR170","doi-asserted-by":"publisher","unstructured":"Gomzikova MO, James V, Rizvanov AA. Mitochondria donation by mesenchymal stem cells: current understanding and mitochondria transplantation strategies. Front Cell Dev Biol. 2021;9. https:\/\/doi.org\/10.3389\/fcell.2021.653322.","DOI":"10.3389\/fcell.2021.653322"},{"key":"819_CR171","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1186\/s40035-024-00409-w","volume":"13","author":"N Song","year":"2024","unstructured":"Song N, Mei S, Wang X, Hu G, Lu M. Focusing on mitochondria in the brain: from biology to therapeutics. Transl Neurodegener. 2024;13:23. https:\/\/doi.org\/10.1186\/s40035-024-00409-w.","journal-title":"Transl Neurodegener"},{"key":"819_CR172","doi-asserted-by":"publisher","first-page":"1028","DOI":"10.1016\/j.apsb.2022.10.008","volume":"13","author":"T Zhang","year":"2023","unstructured":"Zhang T, Miao C. Mitochondrial transplantation as a promising therapy for mitochondrial diseases. Acta Pharm Sin B. 2023;13:1028\u201335. https:\/\/doi.org\/10.1016\/j.apsb.2022.10.008.","journal-title":"Acta Pharm Sin B"},{"key":"819_CR173","doi-asserted-by":"publisher","first-page":"8702","DOI":"10.1007\/s12035-024-04015-9","volume":"61","author":"A Mhaske","year":"2024","unstructured":"Mhaske A, Shukla S, Ahirwar K, Singh KK, Shukla R. Receptor-Assisted nanotherapeutics for overcoming the Blood\u2013Brain barrier. Mol Neurobiol. 2024;61:8702\u201338. https:\/\/doi.org\/10.1007\/s12035-024-04015-9.","journal-title":"Mol Neurobiol"},{"key":"819_CR174","doi-asserted-by":"publisher","unstructured":"Marrache S, Dhar S. Engineering of blended nanoparticle platform for delivery of mitochondria-acting therapeutics. Proc Natl Acad Sci USA. 2012;109:16288\u201393. https:\/\/doi.org\/10.1073\/pnas.1210096109.","DOI":"10.1073\/pnas.1210096109"},{"key":"819_CR175","doi-asserted-by":"publisher","unstructured":"Surnar B, Basu U, Banik B, Ahmad A, Marples B, Kolishetti N, et al. Nanotechnology-mediated crossing of two impermeable membranes to modulate the stars of the neurovascular unit for neuroprotection. Proc Natl Acad Sci USA. 2018;115. https:\/\/doi.org\/10.1073\/pnas.1816429115.","DOI":"10.1073\/pnas.1816429115"},{"key":"819_CR176","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1016\/j.neuropharm.2018.07.014","volume":"145","author":"AM Lamade","year":"2019","unstructured":"Lamade AM, Kenny EM, Anthonymuthu TS, Soysal E, Clark RSB, Kagan VE, et al. Aiming for the target: mitochondrial drug delivery in traumatic brain injury. Neuropharmacology. 2019;145:209\u201319. https:\/\/doi.org\/10.1016\/j.neuropharm.2018.07.014.","journal-title":"Neuropharmacology"},{"key":"819_CR177","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1007\/s00395-021-00898-0","volume":"116","author":"S Comit\u00e0","year":"2021","unstructured":"Comit\u00e0 S, Femmino S, Thairi C, Alloatti G, Boengler K, Pagliaro P, et al. Regulation of STAT3 and its role in cardioprotection by conditioning: focus on non-genomic roles targeting mitochondrial function. Basic Res Cardiol. 2021;116:56. https:\/\/doi.org\/10.1007\/s00395-021-00898-0.","journal-title":"Basic Res Cardiol"},{"key":"819_CR178","doi-asserted-by":"publisher","first-page":"2450","DOI":"10.1038\/s44321-024-00132-z","volume":"16","author":"M Sorge","year":"2024","unstructured":"Sorge M, Savor\u00e9 G, Gallo A, Acquarone D, Sbroggi\u00f2 M, Velasco S, et al. An intrinsic mechanism of metabolic tuning promotes cardiac resilience to stress. EMBO Mol Med. 2024;16:2450\u201384. https:\/\/doi.org\/10.1038\/s44321-024-00132-z.","journal-title":"EMBO Mol Med"},{"key":"819_CR179","doi-asserted-by":"publisher","first-page":"2157","DOI":"10.1007\/s12015-025-10948-y","volume":"21","author":"A Konopko","year":"2025","unstructured":"Konopko A, Kazek M, Waraksa-Zasada E, \u0141ukomska A, Ratajczak J, Kucia M, et al. The NLRP3 inflammasome transmits sterile inflammation signals to sustain proper mitochondrial electron transport chain function and influences cellular metabolism. Stem Cell Rev Rep. 2025;21:2157\u201369. https:\/\/doi.org\/10.1007\/s12015-025-10948-y.","journal-title":"Stem Cell Rev Rep"},{"key":"819_CR180","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1007\/s00395-021-00861-z","volume":"116","author":"C Hirschh\u00e4user","year":"2021","unstructured":"Hirschh\u00e4user C, Lissoni A, G\u00f6rge PM, Lampe PD, Heger J, Schl\u00fcter K-D, et al. Connexin 43 phosphorylation by casein kinase 1 is essential for the cardioprotection by ischemic preconditioning. Basic Res Cardiol. 2021;116:21. https:\/\/doi.org\/10.1007\/s00395-021-00861-z.","journal-title":"Basic Res Cardiol"},{"key":"819_CR181","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1093\/cvr\/cvp157","volume":"83","author":"E Miro-Casas","year":"2009","unstructured":"Miro-Casas E, Ruiz-Meana M, Agullo E, Stahlhofen S, Rodr\u0131\u0301guez-Sinovas A, Cabestrero A, et al. Connexin43 in cardiomyocyte mitochondria contributes to mitochondrial potassium uptake. Cardiovasc Res. 2009;83:747\u201356. https:\/\/doi.org\/10.1093\/cvr\/cvp157.","journal-title":"Cardiovasc Res"},{"key":"819_CR182","doi-asserted-by":"publisher","first-page":"1471","DOI":"10.3390\/ijms24021471","volume":"24","author":"AN Pavlyuchenkova","year":"2023","unstructured":"Pavlyuchenkova AN, Chelombitko MA, Fedorov AV, Kuznetsova MK, Zinovkin RA, Razin E. The distinct effects of the Mitochondria-Targeted STAT3 inhibitors Mitocur-1 and Mitocur-3 on mast cell and mitochondrial functions. Int J Mol Sci. 2023;24:1471. https:\/\/doi.org\/10.3390\/ijms24021471.","journal-title":"Int J Mol Sci"},{"key":"819_CR183","doi-asserted-by":"publisher","unstructured":"Wang L, Ren W, Wu Q, Liu T, Wei Y, Ding J, et al. NLRP3 inflammasome activation: a therapeutic target for cerebral ischemia\u2013reperfusion injury. Front Mol Neurosci. 2022;15. https:\/\/doi.org\/10.3389\/fnmol.2022.847440.","DOI":"10.3389\/fnmol.2022.847440"},{"key":"819_CR184","doi-asserted-by":"publisher","unstructured":"Zhang J, Riquelme MA, Hua R, Acosta FM, Gu S, Jiang JX. Connexin 43 hemichannels regulate mitochondrial ATP generation, mobilization, and mitochondrial homeostasis against oxidative stress. Elife. 2022;11. https:\/\/doi.org\/10.7554\/eLife.82206.","DOI":"10.7554\/eLife.82206"}],"container-title":["Pharmacological Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s43440-025-00819-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s43440-025-00819-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s43440-025-00819-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,13]],"date-time":"2026-01-13T22:14:17Z","timestamp":1768342457000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s43440-025-00819-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,5]]},"references-count":184,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,2]]}},"alternative-id":["819"],"URL":"https:\/\/doi.org\/10.1007\/s43440-025-00819-1","relation":{},"ISSN":["1734-1140","2299-5684"],"issn-type":[{"value":"1734-1140","type":"print"},{"value":"2299-5684","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,5]]},"assertion":[{"value":"30 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 December 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 December 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 January 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have not used artificial intelligence or artificial intelligence-assisted tools for the writing of this manuscript, nor for the creation of images, graphics, tables, or their corresponding captions.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declaration of generative AI and AI-assisted technologies in the manuscript preparation process"}},{"value":"The authors declare no competing interests.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}